PTSD

Mapping How Ayahuasca Affects Fear Circuits: Key Insights From New Research

TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir

VA Funds $1.5M MDMA Study To Treat PTSD In Veterans

TV News Anchor Kendis Gibson Opens Up About Mental Health Struggles And Psychedelic Therapy In New Memoir

VA Funds $1.5M MDMA Study To Treat PTSD In Veterans

Veterans Seek Healing Through Psychedelic Therapy As Seen In New Documentary 'In Waves And War'

Veteran Access To Psychedelic Mental Health Therapies Stalls In Virginia

Veterans Seek Healing Through Psychedelic Therapy As Seen In New Documentary 'In Waves And War'

Veteran Access To Psychedelic Mental Health Therapies Stalls In Virginia

FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays

FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care

PTSD Recent News

Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises

Global psychedelic drugs market to reach $10.2 billion by 2028, driven by mental health needs and evolving regulatory support.

Veterans Affairs Eyes Funding For New MDMA-PTSD Trial After FDA Setback

The VA may fund a new Phase III trial for MDMA therapy to treat PTSD after the FDA rejected Lykos Therapeutics' initial application.

Ukraine's Military Veterans Turn To Ketamine For PTSD Treatment As Advocacy Grows

Ketamine therapy is providing fast relief for PTSD in Ukraine's military veterans, offering new hope for the war-torn nation's emotional recovery.

From Vacation To Legal Nightmare: How A Georgia Veteran's CBD Arrest In Dubai Landed Him Behind Bars

A retired Georgia Navy veteran faces drug trafficking charges in Dubai after being arrested for possessing medically prescribed CBD pills.

Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD

MAPS funds a $200K pilot study at Emory University exploring the synergy between MDMA-assisted therapy and Massed Exposure Therapy for PTSD.

FDA Sets September Meeting To Discuss Psychedelic And Other Treatments For PTSD

FDA schedules public meeting to discuss potential psychedelic treatments for PTSD, inviting input from veterans, advocates and researchers

Psychedelics Enhance Creativity After Use, But MDMA Disrupts Memory, Study Shows

New research reveals distinct cognitive effects of psychedelics and MDMA, showing that psychedelics may impair focus but boost creativity, while MDMA primarily disrupts memory.

Psychedelics And Mental Health: FDA Stalls, But States Forge Ahead

FDA rejects MDMA for PTSD, delaying access to life-saving treatment though some states are introducing psychedelic therapy programs.

FDA Rejects MDMA For PTSD Treatment, Calls For More Research On Psychedelic Therapy

The FDA this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD.

FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand

The FDA is set to decide on MDMA therapy for PTSD, a move that could revolutionize treatment for veterans and others with severe trauma. Here's what's at stake

Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles

A new review finds MDMA therapy for PTSD promising but calls for more research before widespread adoption. Lawmakers urge FDA to reconsider its decision.

Senators Press FDA To Approve MDMA As PTSD Treatment, Stressing US Vets' Suicide Rates As Aug 11 Decision Looms

Bipartisan senators urge FDA to rely on scientific evidence in approving MDMA-Assisted Therapy for PTSD, highlighting its potential to help veterans.

Bipartisan Effort At U.S. Capitol Calls On FDA To Approve MDMA Therapy For Vets And Others With PTSD

Bipartisan lawmakers and veterans push for FDA approval of MDMA therapy for PTSD, marking a milestone in mental health innovation.

How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare

Explore how Healing Realty Trust is transforming psychedelic therapy through strategic real estate investments, paving the way for growth.

FDA Committee 'Completely Lost Sight Of The Big Picture' Says Retired Lieutenant General Urging Approval On MDMA For PTSD

FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates

A committee of advisors to the U.S. Food and Drug Administration (FDA) dealt a blow to the burgeoning field of psychedelic medicine by recommending against the approval of MDMA-assisted therapy as a treatment for PTSD.

Top Federal Drug Official Praises Psychedelics' Potential, Psilocybin And Ketamine On City Health Plans And More

NIDA Director praises psychedelics, NCCIH highlights psilocybin's benefits and Atlanta explores adding psilocybin, ketamine to health plans.

Psychedelics Surpass Cannabis With Unprecedented Bipartisan Support In Congress, Says Top VA Official

Speaking at a Horizons psychedelics conference, VA Under Secretary for Health Shereef Elnahal shared insights on psychedelic medicine

Cannabis And Guns: This Vet Chose The Latter But He Shouldn't Have To, Now He's Going To Federal Court

This vet had to surrender his personal firearms and ammunition or forego the relief provided by medical marijuana. He kept his guns.

Legal Advocate Takes Bold Approach To Address PTSD In Veterans

Courtney Barnes, partner at Feldman Legal Advisors, advocates for psychedelic policy reform, and will be a guest at Benzinga Cannabis Capital Conference.

Groundbreaking: FDA Reviews MDMA Therapy For PTSD, Accepts New Drug Application

Three Key Takeaways:

GOP-Led Senate Bill In Indiana Targets PTSD, Depression With Psilocybin Research For Veterans, First Responders

Indiana legislators are taking aim at mental health and medical issues with a GOP-sponsored Senate bill that would fund state institutions to explore the potential of psilocybin as an alternative treatment for certain mental health disorders.

Veterans Affairs, After Decades, Will Fund Psychedelic Research For Vets With PTSD And Depression

In a groundbreaking move, the U.S. Department of Veterans Affairs (VA) is launching new studies on using psychedelic compounds to treat post-traumatic stress disorder (PTSD) and depression among military veterans.

;